(HealthDay)—Pfizer Inc. announced Tuesday that it has submitted initial data to federal regulators on the efficacy of its COVID-19 vaccine among younger children. The company is also expected to submit the same data on kids aged 5 to 11 to the European Medicines Agency and other regulatory authorities in the next few weeks, CNN reported. […]